• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前胰岛素使用者和非使用者对胰岛素给药系统的偏好。

Preference for insulin delivery systems among current insulin users and nonusers.

作者信息

Summers Kent H, Szeinbach Sheryl L, Lenox Sheila M

机构信息

Purdue University School of Pharmacy and Pharmacy Sciences, West Lafayette, Indiana, USA.

出版信息

Clin Ther. 2004 Sep;26(9):1498-505. doi: 10.1016/j.clinthera.2004.09.009.

DOI:10.1016/j.clinthera.2004.09.009
PMID:15531012
Abstract

BACKGROUND

It is not known whether preferences for the vial and syringe (VS) or the insulin injection pen device (IIPD) differ between current insulin users and nonusers. Additional benefits in treatment might be realized if preference were considered when discussing insulin use with patients initiating or changing insulin treatment.

OBJECTIVE

The objective of this study was to examine respondent preferences for the VS and the IIPD between current insulin users and nonusers.

METHODS

US residents with type 1 or 2 diabetes mellitus who responded to a year-2001 mail survey completed a 19-item self-administered questionnaire designed to assess respondents' expectations of attributes related to the VS and IIPD. Items were analyzed on a 5-point Likert-type scale with higher scores indicating greater agreement that attributes met expectations. Composite scores for ease of use, activity interference, and social acceptability were used to further examine differences between insulin users and nonusers regarding their preferences for the VS or IIPD. Observed differences in preferences were evaluated statistically using the chi-square test, paired Student t test, and regression analysis.

RESULTS

Questionnaires were received from 302 respondents, producing an adjusted response rate of 20.8%. Respondents ranged in age from 18 to 83 years (mean [SD], 52.4 [13.2] years), with 62% reporting annual income above 25,000 US dollars. Of the 242 usable responses, 99 respondents were insulin users and 143 were not. Statistical evaluation using analysis of variance revealed significant regression coefficients (P < or = 0.001) for both insulin users and nonusers for each of the 3 dimensions (ease of use, activity interference, and social acceptability with respect to preference).

CONCLUSIONS

Based on this survey analysis, overall preference for the IIPD appeared to be higher compared with the VS among both insulin users and nonusers. Social acceptability was the strongest predictor of preference for the IIPD. For current insulin users, social acceptability and ease of use were significant predictors of preference for the VS. For insulin nonusers, these results suggested that patient discussions about VS should emphasize activity interference and ease of use.

摘要

背景

目前尚不清楚胰岛素使用者和非使用者对小瓶和注射器(VS)或胰岛素注射笔装置(IIPD)的偏好是否存在差异。在与开始或改变胰岛素治疗的患者讨论胰岛素使用时,如果考虑到偏好因素,可能会在治疗中实现额外的益处。

目的

本研究的目的是调查胰岛素使用者和非使用者对VS和IIPD的偏好。

方法

对2001年邮件调查做出回应的美国1型或2型糖尿病患者完成了一份19项的自填式问卷,旨在评估受访者对与VS和IIPD相关属性的期望。项目采用5点李克特量表进行分析,得分越高表明受访者越认同属性符合期望。使用易用性、活动干扰和社会可接受性的综合得分进一步研究胰岛素使用者和非使用者在对VS或IIPD的偏好方面的差异。使用卡方检验、配对学生t检验和回归分析对观察到的偏好差异进行统计学评估。

结果

共收到302名受访者的问卷,调整后的回复率为20.8%。受访者年龄在18至83岁之间(平均[标准差],52.4[13.2]岁),62%的人报告年收入超过25,000美元。在242份可用回复中,99名受访者为胰岛素使用者,143名不是。使用方差分析的统计评估显示,在三个维度(易用性、活动干扰和关于偏好的社会可接受性)中的每一个维度上,胰岛素使用者和非使用者的回归系数均具有统计学意义(P≤0.001)。

结论

基于本次调查分析,胰岛素使用者和非使用者对IIPD的总体偏好似乎高于VS。社会可接受性是对IIPD偏好的最强预测因素。对于当前的胰岛素使用者,社会可接受性和易用性是对VS偏好的重要预测因素。对于非胰岛素使用者,这些结果表明,在与患者讨论VS时应强调活动干扰和易用性。

相似文献

1
Preference for insulin delivery systems among current insulin users and nonusers.当前胰岛素使用者和非使用者对胰岛素给药系统的偏好。
Clin Ther. 2004 Sep;26(9):1498-505. doi: 10.1016/j.clinthera.2004.09.009.
2
An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.与标准药瓶和注射器相比,对患者对替代胰岛素给药系统的偏好进行评估。
Curr Med Res Opin. 2007 Jan;23(1):133-46. doi: 10.1185/030079906X159524.
3
Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.在一项针对2型糖尿病患者的随机、开放标签、交叉操作研究中,预填充胰岛素输送装置和可重复使用胰岛素输送装置的直观性、指导时间及患者接受度。
Clin Ther. 2008 Dec;30(12):2252-62. doi: 10.1016/j.clinthera.2008.12.004.
4
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.医疗补助计划覆盖的2型糖尿病患者开始胰岛素笔治疗后的医疗费用及药物依从性:一项回顾性数据库分析
Clin Ther. 2007 Jun;29(6 Pt 1):1294-305. doi: 10.1016/j.clinthera.2007.07.007.
5
Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe.开发一种工具,以评估与胰岛素瓶和注射器相比,对胰岛素注射笔的期望和偏好。
Clin Ther. 2004 Apr;26(4):590-7. doi: 10.1016/s0149-2918(04)90061-6.
6
Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.两种预充型胰岛素笔易用性和患者偏好注射模拟研究
Curr Med Res Opin. 2010 Jul;26(7):1745-53. doi: 10.1185/03007995.2010.489028.
7
Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.新型一次性胰岛素笔Solostar与Flexpen、礼来一次性笔及一种原型笔的可用性和患者偏好比较:一项开放标签研究。
Clin Ther. 2007 Apr;29(4):650-60. doi: 10.1016/j.clinthera.2007.04.003.
8
Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.1型糖尿病青少年的生活质量与糖尿病知识:治疗方式和人口统计学特征的影响
J Am Diet Assoc. 2005 Jan;105(1):85-91. doi: 10.1016/j.jada.2004.10.010.
9
Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.新型优泌林/优泌乐3.0毫升预填充胰岛素笔在克罗地亚十个糖尿病中心的患者接受度及可靠性
Med Sci Monit. 2002 Mar;8(3):PI21-6.
10
Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen) in clinical use.一种新型3.0毫升可重复使用胰岛素笔(优伴笔)临床使用的可接受性和安全性。
Diabetes Nutr Metab. 1999 Oct;12(5):306-9.

引用本文的文献

1
Analysis of factors affecting the accuracy of low-dose insulin dosage using syringes and vials: a cross-sectional study in a Japanese regional hospital.使用注射器和药瓶时影响低剂量胰岛素剂量准确性的因素分析:日本一家地区医院的横断面研究。
Diabetol Int. 2024 May 9;15(3):544-549. doi: 10.1007/s13340-024-00726-5. eCollection 2024 Jul.
2
Advantages and disadvantages of connected insulin pens in diabetes management.糖尿病管理中胰岛素笔联网的利弊
Endocr Connect. 2023 Sep 27;12(11). doi: 10.1530/EC-23-0108. Print 2023 Nov 1.
3
The Review of Insulin Pens-Past, Present, and Look to the Future.
胰岛素笔的回顾——过去、现在和未来展望。
Front Endocrinol (Lausanne). 2022 Mar 8;13:827484. doi: 10.3389/fendo.2022.827484. eCollection 2022.
4
A Multicenter, Prospective, Observational, Open-Label Study of the Safety and Comfort of Gensulin Delivery Device Use in a Large Cohort of Adult and Elderly Patients with Type 2 Diabetes.一项多中心、前瞻性、观察性、开放性研究,旨在评估在 2 型糖尿病成年和老年患者大样本中使用 Gensulin 输送装置的安全性和舒适度。
Int J Environ Res Public Health. 2020 Oct 19;17(20):7587. doi: 10.3390/ijerph17207587.
5
Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System.进餐时胰岛素给药系统的实验室及台面性能
J Diabetes Sci Technol. 2018 Jul;12(4):817-827. doi: 10.1177/1932296818760633. Epub 2018 Feb 28.
6
Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch.患者对进餐时胰岛素递送贴片的认知与偏好。
Diabetes Ther. 2018 Feb;9(1):297-307. doi: 10.1007/s13300-017-0365-1. Epub 2018 Jan 11.
7
Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes.2 型糖尿病患者的治疗信念、健康行为及其与治疗结果的关系。
BMJ Open Diabetes Res Care. 2016 Apr 13;4(1):e000166. doi: 10.1136/bmjdrc-2015-000166. eCollection 2016.
8
A Systematic Review of Patients' Perspectives on the Subcutaneous Route of Medication Administration.关于患者对皮下给药途径看法的系统评价
Patient. 2016 Aug;9(4):281-92. doi: 10.1007/s40271-015-0160-x.
9
Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience.新型利拉鲁肽3.0毫克笔式注射器在有或无既往注射经验的超重或肥胖成年患者中的可用性
J Diabetes Sci Technol. 2015 Jul 16;10(1):164-74. doi: 10.1177/1932296815593295.
10
Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study.利司那肽、艾塞那肽和利拉鲁肽笔式装置的比较评估:一项基于用户的初步研究。
J Diabetes Sci Technol. 2014 Jan;8(1):123-131. doi: 10.1177/1932296813511733. Epub 2014 Jan 1.